TSX · BLCO.TO
Bausch + Lomb Corporation
CA$27.94-CA$0.81 (-2.82%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 6.02% below the high.
Loading market information…
OTC · NSCIF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nanalysis Scientific Corp.’s quoted price sits in the lower half of its reported 52-week range, 41.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Nanalysis Scientific Corp.’s next earnings report is currently expected on Nov 23, 2026, with estimated earnings per share of $0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nanalysis Scientific Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 08:00 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 28, 2025 |
| -$0.01 |
| $7.44M-34.75% vs estimate |
| Q1 2025 | Apr 24, 2025 | -$0.05 | $8.54M+11.72% vs estimate |
|---|
| Q3 2024 | Nov 21, 2024 | -$0.01-100.0% vs estimate | $7.81M+17.44% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$27.94-CA$0.81 (-2.82%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 6.02% below the high.
CA$33.40-CA$0.27 (-0.8%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.87% below the high.
$12.27-$0.81 (-6.19%)
AbCellera Biologics Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.31% below the high.
$37.41-$0.13 (-0.35%)
Xenon Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 48.51% below the high.
CA$11.47-CA$0.94 (-7.57%)
Bausch Health Companies Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.33% below the high.
$76.68-$9.06 (-10.57%)
IRadimed Corporation’s quoted price sits in the lower half of its reported 52-week range, 28.93% below the high.
$11.25-$1.60 (-12.45%)
908 Devices Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.73% below the high.
$1.95-$0.02 (-1.02%)
Aclarion, Inc.’s quoted price sits in the lower half of its reported 52-week range, 79.17% below the high.
